Metlife (MET) Receivables - Other (2009 - 2025)

Metlife's Receivables - Other history runs 17 years deep, the most recent figure standing at $46.0 million for Q4 2025.

• On a quarterly basis, Receivables - Other fell 25.81% year-over-year to $46.0 million in Q4 2025; TTM through Dec 2025 was $46.0 million, a 25.81% decrease from a year earlier, with the FY2025 full-year figure at $375.0 million, up 66.67% from the prior year.
• Receivables - Other retreated to $46.0 million in Q4 2025 per MET's latest filing, from $300.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $300.0 million in Q1 2024 and bottomed at $35.0 million in Q4 2021.
• The 5-year median for Receivables - Other is $172.5 million (2021), against an average of $164.8 million.
• Across the five-year window, Receivables - Other surged 316.67% in 2023 and tumbled 75.2% in 2024, its largest moves.
• Year by year, Receivables - Other stood at $35.0 million in 2021, then jumped by 71.43% to $60.0 million in 2022, then jumped by 316.67% to $250.0 million in 2023, then tumbled by 75.2% to $62.0 million in 2024, then decreased by 25.81% to $46.0 million in 2025.
• Per Business Quant, the three latest MET Receivables - Other figures stand at $46.0 million (Q4 2025), $300.0 million (Q1 2025), and $62.0 million (Q4 2024).